Physician profile
Sara Rahimi
NPI 1861927345
$597.79
in general payments reported to CMS, 2019-2025
18 companies · $45.84 in 2025
The $45.84 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $350 · 2022: $15.00 · 2023: $128 · 2024: $59.06 · 2025: $45.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $113.96 | 2023 | Jelmyto |
| Forte Bio-Pharma LLC | $72.91 | 2023-2024 | Prolate, Nalocet |
| 180 Medical, INC. | $46.72 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $45.84 | 2025 | Bard Urinary Drainage Bag |
| Clarus Therapeutics INC. | $45.00 | 2021 | |
| Astellas Pharma US INC | $40.09 | 2021 | |
| Urovant Sciences INC | $27.51 | 2021 | |
| Myovant Sciences INC. | $26.12 | 2021 | |
| Rochester Medical Corporation | $23.63 | 2021 | |
| Boston Scientific Corporation | $23.34 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.28 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.89 | 2021 | |
| Hollister Incorporated | $18.65 | 2021 | |
| Olympus America INC. | $17.66 | 2021 | |
| Glaxosmithkline, LLC. | $15.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $14.87 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $14.32 | 2021 | |
| Janssen Biotech, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Rahimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.